How To (Legally) Make Psychedelic Medicine: CEO of Psygen, Danny Motyka
How To (Legally) Make Psychedelic Medicine: CEO of Psygen, Danny Motyka
Business Trip, a podcast about psychedelic entrepreneurship
Welcome back to Business Trip, a podcast about psychedelic entrepreneurship! 🍄
Episode 6 features Danny Motyka, the founder of Psygen, a Canadian manufacturer of psychedelics, like MDMA, LSD, DMT and synthetic psilocybin.
Psygen makes pharmaceutical grade psychedelic medicines for clinical research and therapeutic applications. They have a license to be one of the first manufacturing facilities dedicated to the synthesis of psychedelic medicine.
In this episode, we discuss:
Behind the scenes of Psygen’s manufacturing process
Natural vs Synthetic psychedelics
Navigating regulations for manufacturing Schedule 1 substances
Listen to the episode here, on Spotify or Apple Podcasts.
About Us
Business Trip tells the story of the emerging industry of psychedelics. Each episode features a new company in the field, ranging from biotech startups developing novel compounds, to clinics and retreats for healing, to software companies building tools to power the ecosystem.
Business Trip is produced by Greg Kubin and Matias Serebrinsky — we’re advocates of the healing powers of psychedelic medicine and see a bright future ahead for the industry.
Thanks for listening,
💖 Know someone who would enjoy Business Trip?